You are currently viewing a new version of our website. To view the old version click .
  • Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).

Cardiovascular Medicine, Volume 7, Issue 11

11 2004 - 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (6)

  • Article
  • Open Access
79 Views
7 Pages

24 November 2004

Background:As part of the PROVE IT-TIMI 22 study the effects of therapy with 40 mg/day pravastatin (aim: standard reduction of a low density lipoprotein [LDL] to 100 mg/dL or 2.6 mmol/L) were compared with those of intensified lipid lowering with 80...

  • Proceeding Paper
  • Open Access
489 Views
10 Pages

Physical Activity in the Prevention of Type 2 Diabetes

  • Gang Hu,
  • Timo A. Lakka,
  • Noël C. Barengo and
  • Jaakko Tuomilehto

24 November 2004

Type 2 diabetes is a common chronic disease with multiple complications, most notably cardiovascular diseases. In the past decade, the associations of physical activity, physical fitness, and changes in the lifestyle with the risk of type 2 diabetes...

  • Proceeding Paper
  • Open Access
69 Views
5 Pages

Myocardial Infarction and Glucose-Insulin-Potassium Infusion: An Overview

  • Jorik R. Timmer,
  • Iwan C. C. van der Horst,
  • Jan Paul Ottervanger,
  • Arnoud W. J. van 't Hof,
  • Henk J. G. Bilo and
  • Felix Zijlstra

24 November 2004

Background: Mortality and infarct size in ST segment elevation myocardial infarction (STEMI) may be reduced by therapies influencing myocardial metabolism, such as infusion of glucose-insulin-potassium (GIK). Although several clinical trials with GIK...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cardiovasc. Med. - ISSN 1664-204X